GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (OTCPK:BMNDF) » Definitions » Short-Term Debt

BMNDF (Biomind Labs) Short-Term Debt : $0.88 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs Short-Term Debt?

Biomind Labs's Short-Term Debt for the quarter that ended in Sep. 2024 was $0.88 Mil.

Biomind Labs's quarterly Short-Term Debt increased from Mar. 2024 ($0.88 Mil) to Jun. 2024 ($1.03 Mil) but then declined from Jun. 2024 ($1.03 Mil) to Sep. 2024 ($0.88 Mil).

Biomind Labs's annual Short-Term Debt stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.74 Mil).

Biomind Labs Short-Term Debt Historical Data

The historical data trend for Biomind Labs's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs Short-Term Debt Chart

Biomind Labs Annual Data
Trend Dec21 Dec22 Dec23
Short-Term Debt
- - 0.74

Biomind Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.74 0.88 1.03 0.88

Biomind Labs Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Biomind Labs Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Biomind Labs's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomind Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (OTCPK:BMNDF) » Definitions » Short-Term Debt
Comparable Companies
TSXV:TTI TSXV:GSD XCNQ:DOSE TSX:HBP TSX:BCT XCNQ:PHRM XCNQ:TELI TSXV:NRX XCNQ:MDMA TSX:SVA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
3XI:Germany BMND:Canada
Address
Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000
Website
https://www.biomindlabs.com
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.